Home
Contracts
All Contracts
Business
Compensation
Corporate
Employment
Fee Agreements
Financials
Financing
Insurance
Leasing
Legal
Licensing
Loans
M&A
Miscellany
Plans
Purchase & Sale
Real Estate
Securities
Services
Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Industries
All Industries
Biotechnology & Drugs
Capital Goods
Commodities
Construction
Consumer
Energy
Financial
Healthcare
Insurance
Miscellany
Real Estate
Retail
Services
Technology
Transportation
Utilities
Subscriptions
Subscriptions
Cancellations
FAQs
Support
About Us
Contact Us
FAQs
Receipts
Services
Sign-In
Home
Home
'Z' Titles
'Z' Titles
Zale Corporation
Zanett, Inc.
Zapata Corporation Announces Proposal to Acquire Remaining Stock of Safety Components International, Inc.
Zenith Completes the Sale of Its Home-Building Business
Zenith Signs Contract to Sell Its Home-Building Business
ZEP Inc.
Zero Coupon Convertible Senior Note
Zero Coupon Subordinated Note
Zoltek Announces Improved Financials From Sale of an Overseas Subsidiary Company
Zoltek Announces Refinancing Package
Zoltek Comments on Positive Development in Patent Infringement Case
Zoltek Companies, Inc.
Zoltek Companies, Inc. Reports Signing of Agreement In Connection with Proposed Refinancing
Zoltek Reports BMW Group Agreement and Progress
Zoltek Reports First Million Pound Order for Carbon Fibers
Zoltek Reports First Quarter Results
Zoltek Reports Fiscal 2003 Fourth Quarter Results And Refinancing of Its Debt
Zoltek Reports Third Quarter Results
Zonagen Amends Modified "Dutch Auction" Tender Offer
Zonagen Announces 2003 Annual Meeting of Stockholders
Zonagen Announces Proposed "Dutch Auction" Tender Offer
Zonagen Authorizes Stock Repurchase Program
Zonagen Commences Modified "Dutch Auction" Tender Offer
Zonagen Provides Update on Proposed "Dutch Auction" Tender Offer
Zonagen Reports Final Results of Self Tender Offer
Zonagen Reports Initial Findings Comparing Androxal to Androgel from U.S. Phase I/II Safety and Efficacy Study in Men with Low Testosterone
Zonagen Reports Preliminary Results of Self Tender Offer
Zonagen to Commence European Study of Progenta in Women with Uterine Fibroids
Zonagen, Inc. and Lavipharm Corp. Sign Definitive Merger Agreement
Zymogenetics, Inc.